Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial. [electronic resource]
Producer: 20160209Description: 696-701 p. digitalISSN:- 1569-8041
- Adenocarcinoma -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Capecitabine -- administration & dosage
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Digestive System Surgical Procedures
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Humans
- Incidence
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- diagnosis
- Neoplasm Staging
- Netherlands -- epidemiology
- Prognosis
- Radiotherapy, Adjuvant
- Rectal Neoplasms -- drug therapy
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.